Scientech Research LLC’s Genpact G Stock Holding History

Scientech Research LLC’s Portfolio G Stock Details G Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,763	Closed	-$283K	–	609
2025 Q3	$283K	Buy	+6,763	New	+$297K	0.1%	395
2024 Q4	–	Sell	-13,277	Closed	-$521K	–	679
2024 Q3	$521K	Buy	+13,277	New	+$480K	0.1%	366
2024 Q2	–	Sell	-14,739	Closed	-$486K	–	632
2024 Q1	$486K	Buy	+14,739	New	+$512K	0.26%	172

Other funds holding G

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NIEF

Nalanda India Equity Fund Mauritius $510M AUM 23.61% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Scientech Research LLC's G Position: Q4 2025 in Review

Scientech Research LLC sold out of Genpact (G) in Q4 2025, closing a stake of 6,763 shares — an estimated $283K sold.

Scientech Research LLC first reported a position in G in Q1 2024 and held it in 3 quarters. The position peaked at $521K in Q3 2024. 522 funds tracked by Wall St. Rank hold G as of Q4 2025.

Scientech Research LLC reported no remaining Genpact position as of Q4 2025 after selling out during the quarter.
Scientech Research LLC sold 6,763 Genpact shares in Q4 2025, an estimated $283K.
Scientech Research LLC first reported a position in Genpact in Q1 2024 and held it in 3 quarters.
Scientech Research LLC's Genpact position peaked at $521K in Q3 2024.
522 funds tracked by Wall St. Rank held Genpact as of Q4 2025.

Based on Scientech Research LLC's 13F filing for Q4 2025, filed 17 Feb 2026.